Deoxyribonucleic acid damage-associated biomarkers of ionising radiation: Current status and future relevance for radiology and radiotherapy

British Journal of Radiology

Volumn 86, Issue 1027, 2013, Pages

  Manning, Grainne ^a   Rothkamm, K ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; EFAPROXIRAL; FLUOROURACIL; HISTONE H2AX; RNA; BIOLOGICAL MARKER;

BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CHROMOSOME ABERRATION; COMPUTER ASSISTED RADIOTHERAPY; CYSTITIS; CYTOGENETICS; DERMATITIS; DICENTRIC CHROMOSOME; DNA DAMAGE; DNA PROBE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EX VIVO STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE EXPRESSION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERVENTIONAL RADIOLOGY; IONIZING RADIATION; LYMPHOCYTE; MAMMOGRAPHY; MICRONUCLEUS TEST; NUCLEIC ACID HYBRIDIZATION; PREMATURE CHROMOSOME CONDENSATION; PROSTATE CANCER; RADIATION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIODIAGNOSIS; RADIOSENSITIVITY; RELATIVE BIOLOGIC EFFECTIVENESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RING CHROMOSOME; TISSUE REACTION; TREATMENT OUTCOME; X RAY; ONCOLOGY; RADIATION INDUCED NEOPLASM; RISK ASSESSMENT;

BIOLOGICAL MARKERS; DNA; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MICRONUCLEUS TESTS; NEOPLASMS, RADIATION-INDUCED; RADIATION ONCOLOGY; RADIATION, IONIZING; RISK ASSESSMENT;

MLCS; MLOWN;

EID: 84880016567     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20130173     Document Type: Review

References (117)

1. International Organisation for Standardisation. Radiation protection-performance criteria for service laboratories performing biological dosimetry by cytogenetics. ISO 19238. Geneva, Switzerland. International Organization for Standardization; 2004.
2. International Organisation for Standardisation. Radiation protection - performance criteria for laboratories performing cytogenetic triage for assessment of mass casualties in radiological or nuclear emergencies - general principles and application to dicentric assay. ISO 19238. Geneva, Switzerland: International Organization for Standardization; 2008.
3. International Atomic Energy Agency. Cytogenetic dosimetry: applications in preparedness for and response to radiation emergencies. Vienna, Austria: International Atomic Energy Agency; 2011.
4. Szluinska M, Edwards AA, Lloyd DC. Statistical methods for biological dosimetry. Chilton, UK: Health Protection Agency; 2005.
5. Lloyd DC, Edwards AA, Moquet JE, Guerrero-Carbajal YC. The role of cytogenetics in early triage of radiation casualities. Appl Radiat Isot 2000;52:1107-12. (Pubitemid 30209982)
6. Vaurijoux A, Gruel G, Pouzoulet F, Grégoire E, Martin C, Roch-Lefèvre S, et al. Strategy for population triage based on dicentric analysis. Radiat Res 2009;171:541-8. doi: 10.1667/RR1664.1.
7. Thierens H, Vral A, Barbé M, Aousalah B, De Riddler L. A cytogenetic study of nuclear power plant workers using the micronucleus- centromere assay. Mutat Res 1999;445:105-11. (Pubitemid 29474939)
8. Thierens H, Vral A, Morthier R, Aousalah B, De Riddler L. Cytogenetic monitoring of hospital workers occupationally exposed to ionizing radiation using the micronucleus centromere assay. Mutagenesis 2000;15:245-9. (Pubitemid 30312715)
9. Thomas P, Umegaki K, Fenech M. Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay. Mutagenesis 2003;18:187 -94.
10. International Atomic Energy Agency. The radiological accident in Istanbul. Vienna, Austria: International Atomic Energy Agency; 2000.
11. Wolff HA, Hennies S, Herrmann M, Rave-Fränk M, Eickelmann D, Virsik P, et al. Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancer. Strahlenther Onkol 2011;187:52-8.
12. Willems P, August L, Slabbert J, Romm H, Oestreicher U, Thierens H, et al. Automated micronucleus (MN) scoring for population triage in case of large scale radiation events. Int J Radiat Biol 2010;86:2-11. doi: 10.3109/09553000903264481.
13. Rossnerova A, Spatova M, Schunck C, Sram RJ. Automated scoring of lymphocyte micronuclei by the MetaSystems Metafer image cytometry system and its application in studies of human mutagen sensitivity and biodosimetry of genotoxin exposure. Mutagenesis 2011;26:169-75. doi: 10.1093/mutage/geq057.
14. Fenech M. The lymphocyte cytokinesisblock micronucleus cytome assay and its application in radiation biodosimetry. Health Phys 2010;98:234-43. doi: 10.1097/HP.0b013e3181b85044.
15. Johnson RT, Rao PN. Mammalian cell fusion: induction of premature chromosome condensation in interphase nuclei. Nature 1970;226:717-22.
16. Pantelias GE, Maillie HD. The use of peripheral blood mononuclear cell prematurely condensed chromosomes for biological dosimetry. Radiat Res 1984;99:140-50. (Pubitemid 14095140)
17. Hatzi VI, Terzoudi GI, Paraskevopoulou C, Makropoulos V, Matthopoulos DP, Pantelias GE. The use of premature chromosome condensation to study the influence of environmental factors on human genetic material in interphase cells. Scientific-World Journal 2006;6:1174-90. doi: 10.1100/tsw.2006.210. (Pubitemid 47279338)
18. Prasanna PG, Blakely WF. Premature chromosome condensation in human resting peripheral blood lymphocytes for chromosome aberration analysis using specific whole-chromosome DNA hybridisation probes. Methods Mol Biol 2005;291:49-57.
19. Hayata I, Kanda R, Minamihisamatsu M, Furukawa M, Sasaki MS. Cytogenetical dose estimation for 3 severely exposed patients in the JCO criticality accident in Tokai-mura. J Radiat Res 2001;42:S149-55.
20. Lindholm C, Stricklin D, Jaworska A, Koivistoinen A, Paile W, Arvidsson E, et al. Premature chromosome condensation (PCC) assay for dose assessment in mass casualty accidents. Radiat Res 2010;173:71-8. doi: 10.1667/RR1843.1.
21. Darroudi F, Natarajan AT, Bentvelzen PA, Heidt PJ, Van Rotterdam A, Zoetelief J. Detection of total- and partial-body irradiation in a monkey model: a comparative study of chromosomal aberration, micronucleus and premature chromosome condensation assays. Int J Radiat Biol 1998;74:207-15. (Pubitemid 28372547)
22. Lindholm C, Edwards A. Long-term persistence of translocations in stable lymphocytes from victims of a radiological accident. Int J Radiat Biol 2004;80:559-66. doi: 10.1080/09553000412331283498. (Pubitemid 39287041)
23. Tawn EJ, Whitehouse CA. Persistence of translocation frequencies in blood lymphocytes following radiotherapy: implications for retrospective radiation biodosimetry. J Radiol Prot 2003;23:423-30. (Pubitemid 38145610)
24. Bauchinger M, Schmid E, Zitzelsberger H, Braselmann H, Nahrstedt U. Radiation-induced chromosome aberrations analysed by two-color fluorescence in situ hybridization with composite whole chromosomespecific DNA probes and a pancentromeric DNA probe. Int J Radiat Biol 1993;64:179-84. (Pubitemid 23266758)
25. Lucas JN, Awa A, Straume T, Poggensee M, Kodama Y, Nakano M, et al. Rapid translocation frequency analysis in humans decades after exposure to ionising radiation. Int J Radiat Biol 1992;62:53-63.
26. Edwards AA, Lindholm C, Darroudi F, Stephan G, Romm H, Barquinero J, et al. Review of translocations detected by FISH for retrospective biological dosimetry applications. Radiat Prot Dosimetry 2005; 113:396-402. doi: 10.1093/rpd/nch452. (Pubitemid 40873450)
27. Sigurdson AJ, Ha M, Hauptmann M, Bhatti P, Sram RJ, Beskid O, et al. International study of factors affecting human chromosome translocations. Mutat Res 2008;652:112-21. doi: 10.1016/j.mrgentox.2008.01.005.
28. Tucker JD, Luckinbill LS. Estimating the lowest detectable dose of ionising radiation by FISH whole-chromosome painting. Radiat Res 2011;175:631-7. doi: 10.1667/RR2506.1.
29. Bhatti P, Yong LC, Doody MM, Preston DL, Kampa DM, Ramsey MJ, et al. Diagnostic X-ray examinations and increased chromosome translocations: evidence from three studies. Radiat Environ Biophys 2010;49:685-92. doi: 10.1007/s00411-010-0307-z.
30. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-strand breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-68. (Pubitemid 28124064)
31. Rothkamm K, Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 2003;100: 5057-62. doi: 10.1073/pnas.0830918100. (Pubitemid 36542657)
32. Rothkamm K, Balroop S, Shekdar J, Fernie P, Goh V. Leukocyte DNA damage after multi-detector row CT: a quantitative biomarker of low-level radiation exposure. Radiology 2007;242:244-51. doi: 10.1148/radiol.2421060171. (Pubitemid 44956030)
33. Sak A, Grehl S, Erichsen P, Engelhard M, Grannass A, Levegrün S, et al. Gamma-H2AX foci formation in peripheral blood lymphocytes of tumour patients after local radiotherapy to different sites of the body: dependence on the dose-distribution, irradiated site and time from start of treatment. Int J Radiat Biol 2007;83:639-52. (Pubitemid 47345867)
34. Horn S, Bernard S, Rothkamm K. Gamma-H2AX-based dose estimation for whole and partial body radiation exposure. PLoS One 2011;6:e25113. doi: 10.1371/journal.pone.0025113.
35. Turner HC, Brenner DJ, Chen Y, Bertucci A, Zhang J, Wang H, et al. Adapting the g-H2AX for automated processing in human lymphocytes. 1. Technological aspects. Radiat Res 2011;175:282-90. doi: 10.1667/RR2125.1.
36. Pope IA, Barber PR, Horn S, Ainsbury E, Rothkamm K, Vojnovic B. A portable microfluidic fluorescence spectrometer device for H2AX-based biological dosimetry. Radiation Measurements 2011;46:907-11. doi: 10.1016/j.radmeas.2011. 02.004.
37. Ainsbury EA, Bakhanova E, Barquinero JF, Brai M, Chumak V, Correcher V, et al. Review of retrospective dosimetry techniques for external ionising radiation exposures. Radiat Prot Dosimetry 2011;147:573-92. doi: 10.1093/rpd/ncq499.
38. Kabacik S, Mackay A, Tamber N, Manning G, Finnon P, Paillier F, et al. Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol 2011;87:115-29. doi: 10.3109/09553002.2010.519424.
39. Amundson SA, Do KT, Fornace AJ Jr. Induction of stress genes by low doses of gamma rays. Radiat Res 1999;152:225-31. (Pubitemid 29413657)
40. Meadows SK, Dressman HK, Muramoto GG, Himburg H, Salter A, Wei Z, et al. Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS One 2008;3: e1912. doi: 10.1371/journal.pone. 0001912.
41. Fält S, Holmberg K, Lambert B, Wennborg A. Long-term global gene expression patterns in irradiated human lymphocytes. Carcinogenesis 2003;24: 1837 - 45. doi: 10.1093/carcin/bgg134.
42. Morandi E, Severini C, Quercioli D, Perdichizzi S, Mascolo M, Horn W, et al. Gene expression changes in medical workers exposed to radiation. Radiat Res 2009; 172:500-8. doi: 10.1667/RR1545.1.
43. Dressman HK, Muramoto GG, Chao NJ, Meadows S, Marshall D, Ginsburg GS, et al. Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med 2007;4:e106. doi: 10.1371/journal.pmed.0040106.
44. Amundson SA, Grace MB, McLeland CB, Epperly MW, Yeager A, Zhan Q. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 2004;64:6368-71. doi: 10.1158/0008-5472.CAN-04-1883. (Pubitemid 39297886)
45. Badie C, Dziwura S, Raffy C, Tsigani T, Alsbeih G, Moody J, et al. Aberrant CDKNIA transcriptional response associates with abnormal sensitivity to radiation treatment. Br J Cancer 2008;98:1845-51. doi: 10.1038/sj.bjc.6604381. (Pubitemid 351748846)
46. Kabacik S, Ortega-Molina A, Efeyan A, Finnon P, Bouffler S, Serrano M, et al. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity. Cell Cycle 2011;10:1152-61.
47. Grace MB, McLeland CB, Gagliardi SJ, Smith JM, Jackson WE 3rd, Blakely WF. Development and assessment of a quantitative reverse transcription-PCR assay for simultaneous measurement of four amplicons. Clin Chem 2003;49:1467-75. (Pubitemid 37011734)
48. Kang CM, Park KP, Song JE, Jeoung DI, Cho CK, Kim TH, et al. Possible biomarkers for ionising radiation exposure in human peripheral blood lymphocytes. Radiat Res 2003;159:312-19. (Pubitemid 36314945)
49. Manning G, Kabacik S, Finnon P, Bouffler S, Badie C. High and low dose responses of transcriptional biomarkers in ex vivo X-irradiated human blood. Int J Radiat Biol Feb 2013. Epub ahead of print. doi: 10.3109/09553002.2013.769694.
50. Brengues M, Paap B, Bittner M, Amundson S, Seligmann B, Korn R, et al. Biodosimetry on small blood volume using gene expression assay. Health Phys 2010;98:179-85. doi: 10.1097/01.HP.0000346706.44253.5c.
51. Meadows SK, Dressman HK, Daher P, Himburg H, Russell JL, Doan P, et al. Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. PLoS One 2010;5: e11535, 2010. doi: 10.1371/journal.pone. 0011535.
52. Gruel G, Voisin P, Vaurijoux A, Roch-Lefevre S, Grégoire E, Maltere P, et al. Broad modulation of gene expression in CD4+ lymphocyte subpopulations in response to low doses of ionising radiation. Radiat Res 2008;170:335-44. doi: 10.1667/RR1147.1.
53. Mori M, Benotmane MA, Tirone I, Hooghe-Peters EL, Desaintes C. Transcriptional response to ionising radiation in lymphocyte subsets. Cell Mol Life Sci 2005; 62:1489-501. doi: 10.1007/s00018-005-5086-3. (Pubitemid 40922951)
54. Bustin SA. Why the need for QPCR publication guidelines? The case for MIQE. Methods 2010;50:217-26. doi: 10.1016/j.ymeth.2009.12.006.
55. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611-22. doi: 10.1373/clinchem.2008. 112797.
56. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29: 365-71. doi: 10.1038/ng1201-365. (Pubitemid 34326681)
57. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, et al. Cancer risks attributable to low doses of ionising radiation: assessing what we really know. Proc Natl Acad Sci U S A 2003;100:13761-6. doi: 10.1073/pnas.2235592100. (Pubitemid 37499140)
58. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84. (Pubitemid 350190758)
59. Stephen AE, Segev DL, Ryan DP, Mullins ME, Kim SH, Schnitzer JJ, et al. The diagnosis of acute appendicitis in a pediatric population: to CTor not to CT. J Pediatr Surg 2003;38:367-71. doi: 10.1053/jpsu.2003.50110. (Pubitemid 36278695)
60. Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst 2008;100:428-36. doi: 10.1093/jnci/djn045. (Pubitemid 351480515)
61. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CTscans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012;380:499-505.
62. Beels L, Bacher K, De Wolf D, Werbrouck J, Thierens H. Gamma-H2AX foci as a biomarker for patient X-ray exposure in pediatric cardiac catheterization: are we understanding radiation risks? Circulation 2009;10:1903-9.
63. Löbrich M, Rief N, Kühne M, Heckmann M, Fleckenstein J, Rübe C, et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci U S A 2005;102:8984-9. doi: 10.1073/pnas.0501895102. (Pubitemid 40881065)
64. Jost G, Golfier S, Pietsch H, Lengsfeld P, Voth M, Schmid TE, et al. The influence of x-ray contrast agents in computed tomography on the induction of dicentrics and gamma-H2AX foci in lymphocytes of human blood samples. Phys Med Biol 2009;54: 6029-39. doi: 10.1088/0031-9155/54/20/001.
65. Frankenberg D, Kelnhofer K, Bär K, Frankenberg-Schwager M. Enhanced neoplastic transformation by mammography X rays relative to 200 kVp X rays: indication for a strong dependence on photon energy of the RBE(M) for various end points. Radiat Res 2002;157:99-105. (Pubitemid 34073393)
66. Göggelmann W, Jacobsen C, Panzer W, Walsh L, Roos H, Schmid E. Re-evaluation of the RBE of 29 kV x-rays (mammography x-rays) relative to 220 kV x-rays using neoplastic transformation of human CGL1-hybrid cells. Radiat Environ Biophys 2003;42:175-82. (Pubitemid 37518061)
67. Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, et al. Effect of chest x-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON and IBCCS collaborators group. J Clin Oncol 2006;24:3361-6. (Pubitemid 46638890)
68. Colin C, Devic C, Noël A, Rabilloud M, Zabot MT, Pinet-Isaac S, et al. DNA double-strand breaks induced by mammographic screening procedures in human mammary epithelial cells. Int J Radiat Biol 2011;87:1103-12. doi: 10.3109/09553002.2011.608410.
69. Office for National Statistics. Breast cancer: incidence, mortality and survival. London, UK: Office for National Statistics; 2010.
70. Hoffman DA, Lonstein JE, Morin MM, Visscher W, Harris BS 3rd, Boice JD 3rd. Breast cancer in women with scoliosis exposed to multiple diagnostic x-rays. J Natl Cancer Inst 1989;81:1307-12. (Pubitemid 19221792)
71. Boice JD Jr, Preston D, Davis FG, Monson RR. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991;125:214-22.
72. Bhatti P, Preston DL, Doody MM, Hauptmann M, Kampa D, Alexander BH, et al. Retrospective biodosimetry among United States radiologic technologists. Radiat Res 2007;167:727-34. doi: 10.1667/RR0894.1. (Pubitemid 351292952)
73. Svensson JP, Stalpers LJ, Esveldt-van Lange RE, Franken NA, Haveman J, Klein B, et al. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 2006;3:e422. doi: 10.1371/journal.pmed.0030422.
74. Badie C, Goodhardt M, Waugh A, Doyen N, Foray N, Calsou P, et al. A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotype. Cancer Res 1997;15:4600-7. (Pubitemid 27441067)
75. Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 1999;1:699-702. (Pubitemid 29332352)
76. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 2009;9:134-42. doi: 10.1038/nrc2587.
77. Crosbie JC, Anderson RL, Rothkamm K, Restall CM, Cann L, Ruwanpura S, et al. Tumor cell response to synchrotron microbeam radiation therapy differs markedly from cells in normal tissues. Int J Radiat Oncol Biol Phys 2010;77:886-94. doi: 10.1016/j.ijrobp.2010.01.035.
78. Rothkamm K, Crosbie JC, Daley F, Bourne S, Barber PR, Vojnovic B, et al. In situ biological dose mapping estimates the radiation burden delivered to "spared" tissue between synchrotron x-ray microbeam radiotherapy tracks. PLoS One 2012;7:e29853. doi: 10.1371/journal.pone.0029853.
79. Chua ML, Somaiah N, Bourne S, Daley F, A'Hern R, Nuta O, et al. Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. Radiother Oncol 2011;99: 225-30. doi: 10.1016/j.radonc.2011.04.009.
80. Rübe CE, Grudzenski S, Kühne M, Dong X, Rief N, Löbrich M, et al. DNA doublestrand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model: implications for radiosensitivity testing. Clin Cancer Res 2008;14: 6546-55. doi: 10.1158/1078-0432.CCR-07-5147.
81. Chan N, Koritzinsky M, Zhao H, Bindra R, Glazer PM, Powell S, et al. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res 2008;68:605-14. doi: 10.1158/0008-5472.CAN-07-5472. (Pubitemid 351380090)
82. Wardman P, Rothkamm K, Folkes LK, Woodcock M, Johnston PJ. Radiosensitization by nitric oxide at low radiation doses. Radiat Res 2007;167:475-84. doi: 10.1667/RR0827.1. (Pubitemid 351292978)
83. Lancaster JR Jr, Xie K. Tumors face NO problems? Cancer Res 2006;66:6459-62. doi: 10.1158/0008-5472.CAN-05-2900. (Pubitemid 44085595)
84. Stea B, Suh JH, Boyd AP, Cagnoni PJ, Shaw E, REACH Study Group. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: determinants of response and its prognostic value for subsequent survival. Int J Radiat Oncol Biol Phys 2006;64:1023-30. doi: 10.1016/j.ijrobp.2005.10.004.
85. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61. doi: 10.1056/NEJM199904153401503. (Pubitemid 29177874)
86. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study. J Clin Oncol 1999;17:1339-48. (Pubitemid 29220838)
87. Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol 2007;19: 397-417. doi: 10.1016/j.clon.2007.03.010. (Pubitemid 46995615)
88. Somaiah N, Yarnold J, Daley F, Pearson A, Gothard L, Rothkamm K, et al. The relationship between homologous recombination repair and the sensitivity of human epidermis to the size of daily doses over a 5-week course of breast radiotherapy. Clin Cancer Res 2012;18:5479-88. doi: 10.1158/1078-0432.CCR-10- 3297.
89. Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, et al. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2012;84:1078-85. doi: 10.1016/j.ijrobp. 2012.02.015.
90. Spratt DE, Pei X, Yamada J, Kollmeier MA, Cox B, Zelefsky MJ. Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2013;85:686-92. doi: 10.1016/j.ijrobp.2012.05.023.
91. Zwicker F, Swartman B, Sterzing F, Major G, Weber K, Huber PE, et al. Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal-vs. step-and-shoot IMRT of the prostate gland. Radiat Oncol 2011;6:62. doi: 10.1186/1748-717X-6-62.
92. Bentzen SM, Hendry JH. Variability in the radiosensitivity of normal cells and tissues. Report from a workshop organised by the European society for therapeutic radiology and oncology in Edinburgh, UK, 19 September 1998. Intl J Radiat Biol 1999;75:513-17. (Pubitemid 29191550)
93. Peacock J, Ashton A, Bliss J, Bush C, Eady J, Jackson C, et al. Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol 2000;55:173-8. (Pubitemid 30229992)
94. Russell N, Grummels A, Hart AA, Smolders IJ, Borger J, Bartelink H, et al. Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. Int J Radiat Biol 1998;73:661-70. (Pubitemid 28320036)
95. Lee TK, Allison RR, O'Brien KF, Johnke RM, Christie KI, Naves JL, et al. Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity. Int J Radiat Oncol Biol Phys 2003;57:222-9. (Pubitemid 36959760)
96. Cantena C, Conti D, Parasacchi P, Marenco P, Bortolato B, Botturi M, et al. Micronuclei in cytokinesis-blocked lymphocytes may predict patient response to radiotherapy. Intl J Radiat Biol 1996;70:301-8.
97. Finnon P, Robertson N, Dziwura S, Raffy C, Zhang W, Ainsbury L, et al. Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation. Hum Genet 2008;123:485-93. doi: 10.1007/s00439-008-0500-1.
98. Camplejohn RS, Hodgson S, Carter N, Kato BS, Spector TD. Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins. Br J Cancer 2006;95:520-4. doi: 10.1038/sj.bjc.6603257. (Pubitemid 44232562)
99. Crompton NE, Miralbell R, Rutz HP, Ersoy F, Sanal O, Wellmann D, et al. Altered apoptotic profiles in irradiated patients with increased toxicity. Int J Radiat Oncol Biol Phys 1999;45:707-14. (Pubitemid 29462653)
100. Crompton NE, Shi YQ, Emery GC, Wisser L, Blattmann H, Maier A, et al. Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 2001;49:547-54. (Pubitemid 32120255)
101. Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, et al. CD4 and CD8 T-lymphocyte assay can predict radiationinduces late toxicity: a prospective study in 399 patients. Clin Cancer Res 2005;11:7426-33. doi: 10.1158/1078-0432.CCR-04-2634. (Pubitemid 41507703)
102. Turesson I, Nyman J, Holmberg E, Odén A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-75. (Pubitemid 27014492)
103. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov J, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.
104. Rieger KE, Hong WJ, Tusher VG, Tang J, Tibshirani R, Chu G. Toxicity from a radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci U S A 2004;101: 6635-40. doi: 10.1073/pnas. 0307761101. (Pubitemid 38586026)
105. Zhan Q, Alamo I, Yu K, Boise LH, Cherney B, Tosato G, et al. The apoptosis-associated gamma-ray response of BCL-X(L) depends on normal p53 function. Oncogene 1996;13:2287-93. (Pubitemid 26412551)
106. Sonis S, Haddad R, Posner M, Watkins B, Fey E, Morgan TV, et al. Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol 2007;43:289-300. (Pubitemid 46228015)
107. Rübe CE, Fricke A, Schneider R, Simon K, Kühne M, Fleckenstein J, et al. DNA repair alterations in children with pediatric malignancies: novel opportunities to identify patients at risk for high-grade toxicities. Int J Radiat Oncol Biol Phys 2010;78:359-69. doi: 10.1016/j.ijrobp.2009.08.052.
108. Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN. Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer 2011;129:2928-34. doi: 10.1002/ijc.25953.
109. Fleckenstein J, Kühne M, Seegmüller K, Derschang S, Melchior P, Gräber S. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011;81:1465-72. doi: 10.1016/j.ijrobp.2010.08.004.
110. Werbrouck J, Duprez F, De Neve W, Thierens H. Lack of a correlation between H2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer. Int J Radiat Biol 2011;87:46-56. doi:10.3109/09553002.2010.518213.
111. Werbrouck J, De Ruyck K, Beels L, Vral A, Van Eijkeren M, De Neve W, et al. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity. Oncol Rep 2010;23:571-8.
112. Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 2003;69:137-44.
113. Borgmann K, Hoeller U, Nowack S, Bernhard M, Röper B, Brackrock S, et al. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:256-64. doi: 10.1016/j.ijrobp.2008.01.007.
114. Chua ML, Somaiah N, A'Hern R, Davies S, Gothard L, Yarnold J, et al. Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy. Radiother Oncol 2011;99: 362-6. doi: 0.1016/j.radonc.2011.05.071.
115. Health Protection Agency. Human radiosensitivity. Report of the independent advisory group on ionising radiation. Chilton, UK: Health Protection Agency; 2013.
116. Movsas B, Moughan J, Owen J, Coia LR, Zelefsky MJ, Hanks G, et al. Who enrolls onto clinical oncology trials? A radiation patterns of care study analysis. Int J Radiat Oncol Biol Phys 2007;68:1145-50. doi: 10.1016/j.ijrobp.2007.01.051. (Pubitemid 47048577)
117. Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol 2012;13:65-77. doi: 10.1016/S1470-2045(11)70302-3.